title: High dose intravenous AAT and plasma neutrophil derived fibrinogen fragments.
authors.forename: J
authors.initials: J
authors.lastname: Stolk
authors.forename: W
authors.initials: W
authors.lastname: Nieuwenhuizen
authors.forename: J K
authors.initials: JK
authors.lastname: Stoller
authors.forename: L
authors.initials: L
authors.lastname: Aboussouan
mesh_terms: D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism; D005541:Forced Expiratory Volume / Q000502:physiology; D006801:Humans; D007262:Infusions, Intravenous; D008171:Lung Diseases / Q000503:physiopathology; D009504:Neutrophils / Q000201:enzymology; D010447:Peptide Hydrolases / Q000378:metabolism; D000515:alpha 1-Antitrypsin / Q000008:administration & dosage*; D019896:alpha 1-Antitrypsin Deficiency / Q000188:drug therapy*
chemical_list: D005338:Fibrin Fibrinogen Degradation Products; D000515:alpha 1-Antitrypsin; D010447:Peptide Hydrolases